BiPAP Management in Patients with Chest Tubes

Indications Requiring BiPAP Discontinuation (Pneumothorax)

BiPAP must be withheld while any pneumothorax is present, regardless of size, because positive‑pressure ventilation can force additional air into the pleural space and worsen the leak. Strong consensus (rating 8/10, good agreement). 1
The recommendation to stop BiPAP applies to patients who were chronically using BiPAP before the pneumothorax developed. 1
In ventilator‑dependent patients, withholding BiPAP may be problematic; ICU‑level observation is advised when BiPAP must be discontinued. Expert panel concern noted. 2

When chest tubes are placed for pleural effusion, empyema, or hemothorax and there is no ongoing air leak, BiPAP is not contraindicated. 3
BiPAP can be continued provided the chest tube is functioning correctly (appropriate water‑seal or suction) and the patient can be closely monitored for complications. [3][4]

Algorithm step 1: If the indication is pneumothorax, discontinue BiPAP until radiographic resolution; if the indication is fluid drainage without air leak, BiPAP may be continued with close monitoring. 1
Algorithm step 2: When BiPAP must be stopped for pneumothorax, assess the patient’s dependence on BiPAP and consider ICU‑level monitoring for severe respiratory compromise. Evaluate the need for invasive mechanical ventilation if adequate gas exchange cannot be maintained without BiPAP. [4][2]5
Algorithm step 3: Continuously verify chest‑tube patency (no kinking, proper drainage), ensure the water‑seal system remains intact, and watch for signs of tension physiology or worsening respiratory status. 3

After pneumothorax resolution and chest‑tube removal, patients should avoid activities that increase intrathoracic pressure for at least 2 weeks, including:
- Air travel – strong consensus. [2][6]3
- Lifting > 5 lb – good consensus. [2][6]
- Spirometry testing – good consensus. [2][6]
BiPAP may be cautiously restarted after this period only if imaging confirms complete resolution of the pneumothorax. 1

Active pneumothorax (any size) is an absolute contraindication to BiPAP; the device must be discontinued immediately. This recommendation is supported by a strong consensus among experts (median rating 8/10)【7】【8】.
Massive hemoptysis is a relative contraindication to BiPAP; experts rated discontinuation with a median score of 8/10【7】【8】【9】.
Scant or mild‑to‑moderate hemoptysis in chronic BiPAP users is generally acceptable; the median rating for discontinuation in these cases was only 2–3/10, indicating low concern for continuation【7】【8】【9】.

During thoracentesis or chest‑tube insertion, PEEP and tidal volume should be left unchanged; altering these settings can cause alveolar derecruitment, hypoxemia, and shift diaphragm position, providing no proven benefit【10】.
Ventilator settings can be safely maintained even with PEEP up to 20 cm H₂O while performing chest‑tube insertion in mechanically ventilated patients【10】.

BiPAP may be resumed only after complete radiographic resolution of the pneumothorax; premature restart is discouraged【7】【8】.
Patients should avoid activities that increase intrathoracic pressure for at least two weeks after pneumothorax resolution, including air travel, lifting > 5 lb, and performing spirometry【7】【8】.